Integration of herbal medicine into evidence-based clinical practice: Current status and issues

Herbal Medicine: Biomolecular and Clinical Aspects: Second Edition

Volumn , Issue , 2011, Pages 453-464

  Zhang, Anthony Lin ^a   Xue, Charlie Changli ^a   Fong, Harry H S ^a,b  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85047101733     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. Awang, D. V. 1997. Quality control and good manufacturing practices: Safety and efficacy of commercial herbs. Food Drug Law J 52:341-4.
2. Awang, D. V., and A. Fugh-Berman. 2002. Herbal interactions with cardiovascular drugs. J Cardiovasc Nurs 16(4):64-70.
3. Barrett, B. 2003. Alternative, complementary, and conventional medicine: Is integration upon us? J Altern Complement Med 9(3):417-27.
4. Blumenthal, M. 2002. Guest editorial: The rise and fall of PC-SPES: New generation of herbal supplement, adulterated product, or new drug? Integr Cancer Ther 1(3):266-70.
5. Boyd, D. B. 2007. Integrative oncology: The last ten years-a personal retrospective. Altern Ther Health Med 13(1):56-64.
6. Brinker, F. 2009. Managing and interpreting the complexities of botanical research. Herbal Gram 82:42-9.
7. Bruno, J. J., and J. J. Ellis. 2005. Herbal use among U.S. elderly: 2002 National Health Interview Survey. Ann Pharmacother 39(4):643-8.
8. Chadwick, L., and H. H. S. Fong. 2006. Herb quality assurance and standardization in herb-drug interaction evaluation and documentation. In Herbal Supplement - Drug Interactions, ed. Y. W. F. Lam, S. M. Huang, and S. D. Hall. New York: Taylor & Francis: 191-203.
9. Cochrane Collaboration. 2009. The Cochrane Library, www.thecochranelibrary.com (accessed June 30, 2009).
10. Cordell, G. A. 2002. PCSPES: A brief overview. Integr Cancer Ther 1(3):271-86.
11. Efficace, F., M. Horneber, S. Lejeune, F. Van Dam, S. Leering, M. Rottmann, and N. K. Aaronson. 2006. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology. J Clin Epidemiol 59(12):1257-65.
12. Ernst, E. 2006. Methodological aspects of traditional Chinese medicine (TCM). Ann Acad Med Singapore 35(11):773-4.
13. Ernst, E., and J. Thompson Coon. 2001. Heavy metals in traditional Chinese medicines: A systematic review. Clin Pharmacol Ther 70(6):497-504.
14. Evans, S. 2008. Changing the knowledge base in Western herbal medicine. Soc Sci Med 67:2098-106.
15. Farnsworth, N. R. 1993. Relative safety of herbal medicines. Herbal Gram 29:36A-367H.
16. Fitzloff, J., P. Yat, and Z. Z. Lu. 1998. Perspectives on the quality assurance of ginseng products in North America. Advances in Ginseng Research - Proceedings of the 7th International Symposium on Ginseng, Seoul, Korea.
17. Fong, H. H. S. 2002. Integration of herbal medicine into modern medical practices: Issues and prospects. Integr Cancer Ther 1(3):287-93.
18. Fong, H. H. S., G. F. Pauli, J. L. Bolton, R. N. van Breemen, S. Banuvar, L. Shulman, S. E. Geller, and N. R. Farnsworth. 2006. Evidence-based herbal medicine: challenges in efficacy and safety assessments. In Annals of Traditional Chinese Medicine Vol 2: Current Review of Chinese Medicine, ed. P. C. Leung, H. H. S. Fong, and C. C. Xue. Singapore: World Scientific: 11-26.
19. Food and Drug Administration. 2007. Dietary supplement current good manufacturing practices (CGMPs) and interim final rule (IFR) facts. Accessed August 2, 2009. http://www.fda.gov/Food/DietarySupplements/GuidanceComplianceRegulatoryInformation/RegulationsLaws/ucm110858.htm.
20. Gagnier, J. J., H. Boon, P. Rochon, D. Moher, J. Barnes, and C. Bombardier. 2006a. Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. J Clin Epidemiol 59(11):1134-49.
21. Gagnier, J. J., H. Boon, P. Rochon, D. Moher, J. Barnes, and C. Bombardier. 2006b. Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement. Ann Intern Med 144(5):364-7.
22. Gagnier, J. J., J. DeMelo, H. Boon, P. Rochon, and C. Bombardier. 2006. Quality of reporting of randomized controlled trials of herbal medicine interventions. Am J Med 119(9):800.e1-11.
23. Geffen, J. R. 2007. From integrative to multidimensional medicine. Altern Ther Health Med 13(1):14-8.
24. Gilroy, C. M., J. F. Steiner, T. Byers, H. Shapiro, and W. Georgian. 2003. Echinacea and truth in labeling. Arch Intern Med 163(6):699-704.
25. Giordano, J., M. K. Garcia, and G. Strickland. 2004. Integrating Chinese traditional medicine into a U.S. public health paradigm. J Altern Complement Med 10(4):706-10.
26. Grimaldi, D. 2008. Integration of complementary and alternative medicine into mainstream health care. J Psychoso Nurs Ment Health Serv 46(10):8-9.
27. Harkey, M. R., G. L. Henderson, M. E. Gershwin, J. S. Stern, and R. M. Hackman. 2001. Variability in commercial ginseng products: An analysis of 25 preparations. Am J Clin Nutr 73(6):1101-6.
28. Henderson, L., Q. Y. Yue, C. Bergquist, B. Gerden, and P. Arlett. 2002. St. John's wort (Hypericum perforatum): Drug interactions and clinical outcomes. Br J Clin Pharmacol 54(4):349-56.
29. Hu, Z., X. Yang, P. C. Ho, S. Y. Chan, P. W. Heng, E. Chan, W. Duan, H. L. Koh, and S. Zhou. 2005. Herb-drug interactions: A literature review. Drugs 65(9):1239-82.
30. Huang, W. F., K. C. Wen, and M. L. Hsiao. 1997. Adulteration by synthetic therapeutic substances of traditional Chinese medicine in Taiwan. J Clin Pharmacol 37:344-50.
31. Institute of Medicine. 2005. Complementary and Alternative Medicine in the United States. Washington, DC: The National Academies Press.
32. International Conference on Harmonization. 2010. ICH guidelines. http://www.ich.org/cache/compo/276-254-1.html (accessed November 26, 2010).
33. Jobst, K. A. 2009. Editorial: Becoming and growing-what does integration mean? J Altern Complement Med 15(4):iii-iv.
34. Johne, A., J. Brockmoller, S. Bauer, A. Maurer, M. Langheinrich, and I. Roots. 1999. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther 66(4):338-45.
35. Joos, S., B. Musselmann, and J. Szecsenyl. 2009. Integration of complementary and alternative medicine into family practice in Germany: Results of a national survey. eCAM 1-8. Epub, March 17, 2009.
36. Kennedy, J. 2005. Herb and supplement use in the U.S. adult population. Clin Ther 27(11):1847-58.
37. Kennedy, J., C. C. Wang, and C. H. Wu. 2008. Patient disclosure about herb and supplement use among adults in the U.S. eCAM 5(4):451-6.
38. Lenon, G. B., C. C. Xue, D. F. Story, F. Thien, and D. G. Li. 2009. Inhibition of release of inflammatory mediators in rat peritoneal mast cells and murine macrophages by a Chinese herbal medicine formula (RCM-102). Phytother Res 23(9):1270-5.
39. Leung, K. F., F. B. Liu, L. Zhao, J. Q. Fang, K. Chan, and L. Z. Lin. 2005. Development and validation of the Chinese quality of life instrument. Health Qual Life Outcomes 3:26.
40. Li, X. M., and L. Brown. 2009. Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J Allergy Clin Immunol 123(2):297-306; quiz 307-8.
41. Liva, R. 2009. Controlled testing: The cornerstone of all quality natural products. Integr Med 8(2):40-2.
42. Long, A. F. 2002. Outcome measurement in complementary and alternative medicine: Unpicking the effects. J Altern Complement Med 8(6):777-86.
43. Mahady, G. B., H. H. S. Fong, and N. R. Farnsworth. 2001. Botanical Dietary Supplements: Quality, Safety and Efficacy. Lisse, The Netherlands: Swets & Zeitlinger Publishers.
44. Ruggle, M. 2005. Mainstreaming complementary therapies: New directions in health care. Health Affairs 24:980-90.
45. Scaglione, F., M. Pannacci, and O. Petrini. 2005. The standardised G115 Panax ginseng C. A. Meyer extract: A review of its properties and usage. Evid-Based Integr Med 2(4):195-206.
46. Schulz, K. F., I. Chalmers, R. J. Hayes, and D. G. Altman. 1995. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273(5):408-12.
47. Schulz, V., W. D. Hubner, and M. Ploch. 1997. Clinical trials with phytopharmacological agents. Phytomedicine 4:379-87.
48. Shang, H., J. Zhang, M. Clarke, B. Zhang, and Y. Li. 2008. Evidence-based medicine in traditional Chinese medicine: Collision and combination. J Altern Complement Med 14:893-4.
49. Sherman, K. J., C. J. Hogeboom, D. C. Cherkin, and R. A. Deyo. 2002. Description and validation of a noninvasive placebo acupuncture procedure. J Altern Complement Med 8(1):11-9.
50. Slifman, N. R., W. R. Obermeyer, B. K. Aloi, S. M. Musser, W. A. Correll Jr., S. M. Cichowicz, J. M. Betz, and L. A. Love. 1998. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 339(12):806-11.
51. Tang, Y. P., Q. C. Wu, A. W. Ding, and J. Duan. 2009. Modern understanding for eighteen incompatible medicaments and nineteen medicaments of mutual restraint in TCM. Chin J Exp Tradit Med Formula 15(6):79-81.
52. Tang, J. L., S. Y. Zhan, and E. Ernst. 1999. Review of randomised controlled trials of traditional Chinese medicine. BMJ 319(7203):160-1.
53. Ulbricht, C., W. Chao, D. Costa, E. Rusie-Seamon, W. Weissner, and J. Woods. 2008. Clinical evidence of herb-drug interactions: A systematic review by the natural standard research collaboration. Curr Drug Metab 9(10):1063-120.
54. Weng, X. G., S. Q. Nie, and L. Y. Huang. 2004. Determination of content changes of hypaconitine in preparations of aconite matching other herbs in "pinellia tuber, snake gourd fruit, fritillaria, Japanese ampelopsis root and common bletilla tuber counteract aconite" by HPLC. Chin Pharm J 39(1):57-9.
55. World Health Organization. 1993. Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines. Geneva: World Health Organization.
56. World Health Organization. 1998. Regulatory Situation of Herbal Medicines. A Worldwide Review. Geneva: World Health Organization.
57. World Health Organization. 2000a. Traditional and Modern Medicine, Harmonizing the Two Approaches. Manila: World Health Organization, Western Pacific Region.
58. World Health Organization. 2000b. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. WHO/EDM/TRM/2000.1. Geneva: World Health Organization.
59. World Health Organization. 2001. Legal Status of Traditional Medicine and Complementary/Alternative Medicine: A Worldwide Review. WHO/EDM/TRM/2001.2. Geneva: World Health Organization.
60. World Health Organization. 2003. WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. Geneva: World Health Organization.
61. World Health Organization. 2004. Report on the Second Consultation Meeting on Traditional and Modern Medicine: Harmonizing the Two Approaches. Manila, Philippines: World Health Organization.
62. World Health Organization. 2006. WHO Monograph on Good Agricultural and Collection Practices (GACP) for Artemisia annua L. Geneva: World Health Organization.
63. World Health Organization. 2007a. WHO Guidelines for Assessing Quality of Herbal Medicines with Reference to Contaminants and Residues. Geneva: World Health Organization.
64. World Health Organization. 2007b. WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicines. Geneva: World Health Organization.
65. World Health Organization. 2008. WHO Congress on traditional medicine. Accessed August 2, 2009. http://www.who.int/dg/speeches/2008/20081107/en/index.html.
66. Wu, D., S. Lai, L. Zhou et al. 2009. Further validation of the health scale of traditional Chinese medicine (HSTCM). Chin Med 4(1):8.
67. Xiao, Z. J., H. Huang, C. H. Zheng, X. B. Zheng, and Y. H. He. 2005. The influence of Radix aconiti matched with Fritillaria to heart function of rat. J Jiangxi TCM e117(2):50-1.
68. Xue, C. C. L., H. M. Hügel, C. G. Li, and D. F. Story. 2004. Efficacy, chemistry and pharmacology of Chinese herbal medicine for allergic rhinitis. Curr Med Chem 11(11):1403-21.
69. Xue, C. C., F. C. Thien, J. J. Zhang, C. Da Costa, and C. G. Li. 2003. Treatment for seasonal allergic rhinitis by Chinese herbal medicine: A randomized placebo controlled trial. Altern Ther Health Med 9(5):80-7.
70. Yue, Q. Y., C. Bergquist, and B. Gerden. 2000. Safety of St. John's wort (Hypericum perforatum). Lancet 355(9203):576-7.
71. Zhang, G. J., and G. L. Li. 2009. Treatment of angina with combination of wutou, gualou and banxia. J Hebei TCM Pharmacol 24(1):46.
72. Zhang, A. L., D. F. Story, V. Lin, L. Vitetta, and C. C. Xue. 2008. A population survey on the use of 24 common medicinal herbs in Australia. Pharmacoepidemiol Drug Saf 17(10):1006-13.
73. Zhou, S. F., Z. W. Zhou, C. G. Li, X. Chen, X. Yu, C. C. Xue, and A. Herington. 2007. Identification of drugs that interact with herbs in drug development. Drug Discov Today 12(15-16):664-73.